These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16968336)

  • 1. Public injecting and the need for 'safer environment interventions' in the reduction of drug-related harm.
    Rhodes T; Kimber J; Small W; Fitzgerald J; Kerr T; Hickman M; Holloway G
    Addiction; 2006 Oct; 101(10):1384-93. PubMed ID: 16968336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Route transition interventions: potential public health gains from reducing or preventing injecting.
    Bridge J
    Int J Drug Policy; 2010 Mar; 21(2):125-8. PubMed ID: 20167464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver's safer injection facility.
    Kerr T; Small W; Moore D; Wood E
    Int J Drug Policy; 2007 Jan; 18(1):37-45. PubMed ID: 17689342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Safer environment interventions': a qualitative synthesis of the experiences and perceptions of people who inject drugs.
    McNeil R; Small W
    Soc Sci Med; 2014 Apr; 106():151-8. PubMed ID: 24561777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Taking away the chaos": a health needs assessment for people who inject drugs in public places in Glasgow, Scotland.
    Tweed EJ; Rodgers M; Priyadarshi S; Crighton E
    BMC Public Health; 2018 Jul; 18(1):829. PubMed ID: 29973179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.
    Rhodes T; Watts L; Davies S; Martin A; Smith J; Clark D; Craine N; Lyons M
    Soc Sci Med; 2007 Aug; 65(3):572-85. PubMed ID: 17475383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV, injecting drug use and harm reduction: a public health response.
    Ball AL
    Addiction; 2007 May; 102(5):684-90. PubMed ID: 17506148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public injecting drug use and the social production of harmful practice in high-rise tower blocks (London, UK): a Lefebvrian analysis.
    Parkin S; Coomber R
    Health Place; 2011 May; 17(3):717-26. PubMed ID: 21440483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk environments and drug harms: a social science for harm reduction approach.
    Rhodes T
    Int J Drug Policy; 2009 May; 20(3):193-201. PubMed ID: 19147339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent blue lights, injecting drug use and related health risk in public conveniences: findings from a qualitative study of micro-injecting environments.
    Parkin S; Coomber R
    Health Place; 2010 Jul; 16(4):629-37. PubMed ID: 20167527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "We need somewhere to smoke crack": An ethnographic study of an unsanctioned safer smoking room in Vancouver, Canada.
    McNeil R; Kerr T; Lampkin H; Small W
    Int J Drug Policy; 2015 Jul; 26(7):645-52. PubMed ID: 25683138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study.
    Kerr T; Stoltz JA; Tyndall M; Li K; Zhang R; Montaner J; Wood E
    BMJ; 2006 Jan; 332(7535):220-2. PubMed ID: 16439401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents, sex and injecting drug use: risks for HIV infection.
    Barnard M; McKeganey N
    AIDS Care; 1990; 2(2):103-16. PubMed ID: 2085532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping violence and policing as an environmental-structural barrier to health service and syringe availability among substance-using women in street-level sex work.
    Shannon K; Rusch M; Shoveller J; Alexson D; Gibson K; Tyndall MW;
    Int J Drug Policy; 2008 Apr; 19(2):140-7. PubMed ID: 18207725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the experience of drug dealing risk environments: an ethnographic case study.
    Fitzgerald JL
    Int J Drug Policy; 2009 May; 20(3):261-9. PubMed ID: 19171472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring motivations to stop injecting in English prisons: qualitative research with former male prisoners.
    Tompkins CN
    Int J Prison Health; 2013; 9(2):68-81. PubMed ID: 25758439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing prevalence of HIV, and persistent high-risk behaviours among drug users in Bangladesh: need for a comprehensive harm reduction programme.
    Islam MM; Conigrave KM
    Drug Alcohol Rev; 2007 Jul; 26(4):445-54. PubMed ID: 17564883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peer-assisted injection as a harm reduction measure in a supervised consumption service: a qualitative study of client experiences.
    Pijl E; Oosterbroek T; Motz T; Mason E; Hamilton K
    Harm Reduct J; 2021 Jan; 18(1):5. PubMed ID: 33407575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.